According to Adicet Bio's latest financial reports and stock price the company's current number of shares outstanding is 42,980,641. At the end of 2023 the company had 42,980,641 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 42.98 M | 3.19% |
2022 | 41.65 M | 22.82% |
2021 | 33.91 M | 72.86% |
2020 | 19.61 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Novartis NVS | 2,062,000,000 | 4,697.51% | ๐จ๐ญ Switzerland |
Pfizer PFE | 5,647,000,000 | 13,038.47% | ๐บ๐ธ USA |
Merck MRK | 2,554,166,667 | 5,842.60% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 2,508.15% | ๐ฎ๐ฑ Israel |
Hawkins HWKN | 20,781,632 | -51.65% | ๐บ๐ธ USA |
Quaker Houghton KWR | 17,908,754 | -58.33% | ๐บ๐ธ USA |